hepatic fibrosisHypertensiontype 2 diabetes mellitusT2DMFIB-4CKDchronic kidney disease
…e 2 diabetes mellitus (T2DM) are predominant causes of CKD, and hepatic fibrosis is highly prevalent in this population, but not integrated into…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 121 of 2459celecoxibcapecitabinepegylated liposomal doxorubicintopical diclofenacchemotherapyHand-foot syndrome (HFS)CochraneScopuschemotherapies
…rmacological strategies to prevent HFS. Although urea cream and celecoxib have shown promising results, the efficacy of topical diclofena…
advanced heart failurePalliative careSinoMedCNKICQVIPCINAHLMedlineWANFANG DATAWeb of Science
…e heart function and reduce readmission rates for patients with advanced heart failure. However, it does not reduce the mortality rate. This article c…
aspirinclopidogrelruptured cerebral aneurysmssubarachnoid haemorrhageticagrelorischaemic strokeintracranial haemorrhage
…ic or haemorrhagic outcomes between the aspirin+clopidogrel and aspirin+ticagrelor regimens. However, the observed differences in survi…
type 2 diabetesRotating night shift workGDMNurses’ Health Study IIgestational diabetes mellitus (GDM)
… with a history of GDM, an exceptionally high-risk subgroup for type 2 diabetes.…
ICHMIEENRICHintracerebral hemorrhage (ICH)MIEIntracerebral Hemorrhage
…n (24%) respondents continue to recommend MIE for basal ganglia ICH. Among the 61 respondents whose practice did not change after E…
96.2%
pre-eclampsiaSubclinical atherosclerosisCVD
…orts the importance of early follow-up in patients who have had pre-eclampsia.…
VancomycinGram-positive infections
… Internal trust guideline.2024.Patel J, Lucas C, Ryan J, et al. Vancomycin therapeutic drug monitoring in paediatrics. Paediatr Child Heal…
Kawasaki diseaseAspirinadalimumabinfliximabmethylprednisolonepolyarticular juvenile idiopathic arthritis
…Kawasaki disease is an acute vasculitis affecting predominantly medium and small…
megestrol acetatepalonosetrongastric or gastro-oesophageal junction canceroxaliplatin-inducedOxaliplatingastric and gastro-oesophageal junction canceroxaliplatin-baseddexamethasoneSichuan University
… junction cancer and (3) support the potential incorporation of megestrol acetate into standard antiemetic medications.Ethics and dissemination T…
dulaglutidetirzepatidetype 2 diabetesT2D
…d consistent improvements in HbA1c and weight reductions versus dulaglutide across all baseline subgroups evaluated. These results indicate…
atezolizumabdurvalumabtremelimumabHCCDur/Trebevacizumabhepatocellular carcinomaAtez/BevAtez/Bev
…Background Combination immunotherapies such as atezolizumab plus bevacizumab (Atez/Bev) and durvalumab plus tremelimumab (D…